Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

Study Identifier:
CUSA-081-HEM-01
ClinicalTrials.gov Identifier:
NCT03594175
EudraCT Identifier:
2019-002124-32
Study Contact Information:
N/A
Terminated/Withdrawn

Trial Documents

Unmapped
Available Languages: English
Download document(s)

Study Details

Medical Condition
  • Thrombosis
Study Drug
  • Drug: CUSA-081
  • Drug: Placebo
  • Drug: Alteplase
Date
Feb 2020 - Jun 2023
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information
Healthy Volunteers
No

Protocol Summary

To evaluate the efficacy and safety of CUSA-081 (diluted reteplase) in the restoration of central venous access device (CVAD) functionality in participants 18 years and older.

Study Locations

Location
Status
Location
Chiesi Investigational Site
Little Rock, Arkansas, United States, 72205
Status
N/A
Location
Chiesi Investigational Site
Redlands, California, United States, 92373
Status
N/A
Location
Chiesi Investigational Site
Stockton, California, United States, 95204
Status
N/A
Location
Chiesi Investigational Site
Norwich, Connecticut, United States, 06360
Status
N/A
Location
Chiesi Investigational Site
Newark, Delaware, United States, 19718
Status
N/A
Location
Chiesi Investigational Site
Jacksonville, Florida, United States, 32209
Status
N/A